Haluk ÇOKUĞRAŞ, Yıldız CAMCIOĞLU, Fatma Deniz AYGÜN, Pınar Özge AVAR-AYDIN

Different clinical spectrum of leptospirosis

Aygün FD, Avar-Aydın PÖ, Çokuğraş H, Camcıoğlu Y. Different clinical spectrum of leptospirosis. Turk J Pediatr 2016; 58: 212-215.Leptospirosis is a prevalent zoonotic disease. Human infection usually occurs through exposure to environmental sources. Clinical course of leptospirosis is variable. We presented five patients, aged between 4-14 years, having a history of contact with rodents and symptoms 7-10 days after contact. The first three cases were relatives and had contact with dead rats after applying insecticides to bakery across from their house. The first case diagnosed as isolated meningitis, others as flu-like illness. The fourth case had a contact history with a rat inundate in the canalization and diagnosed as acute hepatitis. The last case, living in a village with poor sanitation, developed secondary hemophagocytic syndrome. ELISA was performed for diagnosis. High dose penicillin and additional immunosuppressive drugs for the last case were used. All cases showed recovery within 10 days. Leptospirosis should be considered in any patient presenting with an abrupt onset or prolonged fever, myalgia, headache and jaundice.

PDF

___

1. Long SS, Pickering LK, Prober CG. Principles and Practice of Pediatric Infectious Diseases (4th ed). Philadelphia: Elsevier Churchill Livingstone; 2012: 949-952.
2. Levett PN, Haake DA. Leptospira species (leptospirosis). In: Mandell GL, Bennett JE, Dolin R (ed). Principles and Practice of Infectious Diseases (7th ed). Philadelphia: Elsevier Churchill Livingstone; 2009: 3059-3065.
3. Bharti AR, Nally JE, Ricaldi JN, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 2003; 3: 757-771.
4. Pappas G, Papadimitriou P, Siozopoulou V, Christou L, Akritidis N. The globalization of leptospirosis: worldwide incidence trends. Int J Infect Dis 2008; 12: 351-357.
5. Dupouey J, Faucher B, Edouard S, et al. Human leptospirosis: An emerging risk in Europe? Comp Immunol Microbiol Infect Dis 2014; 37: 77-83.
6. World Health Organization. Human Leptospirosis: Guidance for Diagnosis, Surveillance and Control. WHO; Geneva, Switzerland; 2003. Available at: http://www.who.int/csr/don/en/WHO_CDS_CSR_ EPH_2002.23.pdf
7. Shah I. Leptospirosis. Ped Infect Dis 2012; 4: 4-8.
8. Jha S, Ansari MK. Leptospirosis presenting as acute meningoencephalitis. J Infect Dev Ctries 2010; 4: 179- 182.
9. Krishnamurthy S, Mahadevan S, Mandal J, Basu D. Leptospirosis in association with hemophagocytic syndrome: a rare presentation. Indian J Pediatr 2013; 80: 524-525.
10. Picardeau M, Bertherat E, Jancloes M, Skouloudis AN, Durski K, Hartskeerl RA. Rapid tests for diagnosis of leptospirosis: current tools and emerging technologies. Diagn Microbiol Infect Dis 2014; 78: 1-8.